A cell and gene therapy facility makes a batch that is often one patient’s dose, cannot be remade, and is manufactured largely in closed, single-use equipment inside classified suites. That combination changes what the process contractor builds: less large-scale stainless, more suites, more utilities to closed equipment, more airlocks and material flows, and utilities that must never be the reason a batch is lost. Paul Industries builds the classified suites, clean utilities, process piping and equipment connections for autologous and allogeneic cell therapy, viral vector and plasmid manufacturing, under 21 CFR 211 and 1271 and the FDA and EU GMP expectations for advanced therapy medicinal products.
What is different about the process
| Conventional biologics | Cell and gene therapy |
|---|---|
| Large stainless bioreactors, one product, campaigns | Small closed single-use systems, many patient-specific or small allogeneic batches in parallel |
| Bulk WFI, CIP/SIP of fixed equipment | WFI for buffers and cleaning of the suite, little CIP of product equipment; sterile single-use consumables |
| Product tolerates hold times and re-processing | Living cells with short viability windows; no reprocessing; chain of identity and custody through the plant |
| Grade C/D process floor with Grade A/B fill area | Multiple Grade B or C suites for open steps, Grade C/D for closed steps, each with its own airlocks |
| Steam sterilization of equipment | Gamma- or EO-sterilized consumables; autoclaves for waste and small equipment; VHP decontamination of suites and isolators |
Suite design: closed versus open steps
The governing question for every step is whether it is closed. A step performed inside a functionally closed single-use system (a closed bioreactor, a closed cell washer, a welded tube set) can sit in a Grade C or D room; a step that opens the product to the room (manual manipulation in a biosafety cabinet, open vial filling) needs a Grade A device in a Grade B background. A facility is therefore a set of suites at different grades connected by personnel and material airlocks, with unidirectional flow, segregation between patients’ batches and between viral-vector and cell operations, and pressure cascades that also handle containment for viral vectors. Getting the closed/open classification right per unit operation before the suites are drawn decides the size of the classified area and most of the cost.
Utilities to closed equipment
Closed single-use equipment still needs utilities: process gases (CO2, oxygen, nitrogen, compressed air) at controlled quality through sterile filters, WFI or purified water for buffer and media preparation, clean steam where autoclaves and any fixed equipment require it, vacuum, and chilled water or glycol to incubators and controlled-rate freezers. Each enters the suite through sealed penetrations, terminates at a validated point of use, and is qualified. Utilities are also where a CGT facility loses batches: a gas supply interruption, a temperature excursion in an incubator loop or a WFI excursion during buffer prep can take a patient’s dose with it, so redundancy and monitoring are designed in.
Cryogenic and cold chain
Liquid nitrogen supply to controlled-rate freezers and cryogenic storage is a utility system with its own safety design: bulk tank, vacuum-insulated piping, oxygen depletion monitoring in every room with LN2, ventilation and relief. Cryo storage rooms are laid out for chain-of-custody, with monitored freezers and backup supply. Sample and product transfer between suites and storage follows a validated route with temperature logging.
Viral vector operations
Vector manufacture (lentiviral, AAV, retroviral) adds biosafety containment to GMP: suites at negative pressure to the corridor for containment while maintaining a positive relationship to less-clean spaces for product protection, effluent decontamination or kill systems for liquid waste, autoclaving or chemical inactivation of solid waste, and segregation from cell-processing suites. The pressure cascade is more complex than in a conventional plant and has to be designed and tested as one system.
Decontamination and cleaning
With little fixed stainless product equipment, cleaning in a CGT facility is cleaning of the suite and the isolators: vaporized hydrogen peroxide decontamination of isolators and, in some designs, of rooms, with generators, distribution and aeration; sporicidal cleaning of surfaces; and autoclaving of small equipment and waste. Materials, finishes and seals are chosen to survive VHP and sporicides, and the HVAC is designed to isolate a suite during decontamination.
Where the capacity is being built
Cell and gene therapy manufacturing is concentrated around the Boston and Cambridge cluster, Philadelphia, the Research Triangle, the San Francisco Bay Area and Maryland, in both large purpose-built plants and, increasingly, converted laboratory and light-industrial buildings. Conversions are where modular suites, careful HVAC design and utility routing through existing structure matter most, and where a contractor that can do the suites, utilities and process connections in one scope keeps the schedule.
What Paul Industries builds
Classified suites at Grade B, C and D with airlocks, pressure cascades and VHP-compatible finishes; clean utilities including WFI and purified water, process gases, clean steam and vacuum to validated points of use; liquid nitrogen and cryogenic piping with oxygen monitoring; glycol and chilled water to incubators and freezers; sanitary process piping and buffer and media preparation systems; autoclave installation; effluent decontamination for vector suites; and installation and connection of closed processing equipment, isolators and biosafety cabinets supplied by their manufacturers, with the qualification support the facility needs.
Standards referenced: EU GMP Annex 1 (EudraLex Vol. 4) · 21 CFR 211 · 21 CFR 1271 · ISO 14644-1 · ASME BPE · USP <1231> (usp.org)
Frequently asked questions
What makes a cell and gene therapy facility different to build?
Small, often patient-specific batches made in closed single-use equipment across multiple classified suites, with living product that cannot be reprocessed. The build is more suites, airlocks and utilities to closed equipment and less large stainless, with utilities designed for redundancy because a utility failure can cost a patient’s dose.
What cleanroom grades does a cell therapy facility need?
It depends on whether each step is closed. Closed single-use operations can sit in Grade C or D rooms; open manipulations need a Grade A device (biosafety cabinet or isolator) in a Grade B background. Most facilities are a set of Grade B, C and D suites connected by airlocks, with the closed/open classification per unit operation deciding the classified area.
What is closed processing in cell and gene therapy?
Performing a unit operation inside a functionally closed system, a closed bioreactor, cell washer or welded tube set, so the product is never exposed to the room. Closed steps can be done in less stringent rooms, reduce contamination risk and allow parallel batches; the regulators expect the closure to be demonstrated, not assumed.
What utilities does a cell and gene therapy suite need?
Process gases (CO2, oxygen, nitrogen, compressed air) through sterile filters at controlled quality; WFI or purified water for buffer and media preparation; clean steam for autoclaves and any fixed equipment; vacuum; chilled water or glycol to incubators and controlled-rate freezers; and liquid nitrogen for cryogenic storage, each through sealed penetrations to a validated point of use.
How is liquid nitrogen supplied in a cell therapy facility?
From a bulk tank through vacuum-insulated piping to controlled-rate freezers and cryogenic storage, with oxygen depletion monitoring in every room containing LN2, ventilation and pressure relief. Cryo storage is laid out for chain of custody with monitored freezers and backup supply, because the cold chain is part of the product’s identity.
Do cell and gene therapy plants need WFI?
Usually, for buffer and media preparation and for final rinse of any product-contact equipment; some processes use purified water where the buffer is sterile-filtered downstream. The volume is smaller than in a biologics plant, so generation is often a compact membrane or small still with a hot or ozonated loop to a few points of use.
How are viral vector suites different from cell processing suites?
They add biosafety containment to GMP: negative pressure to the corridor for containment while protecting product, effluent decontamination or kill systems for liquid waste, autoclaving or chemical inactivation of solid waste, and segregation from cell processing so vector and cells never share a suite or an air system. The pressure cascade is designed and tested as one system.
What is VHP decontamination and how does it affect construction?
Vaporized hydrogen peroxide decontamination of isolators and, in some designs, whole suites, using generators, distribution and aeration cycles. Room materials, finishes, seals, instruments and HVAC dampers must survive repeated exposure, and the HVAC must isolate the suite during a cycle, which is designed in rather than retrofitted.
Can a laboratory or light-industrial building be converted to a cell therapy facility?
Yes, and many are: modular suites inside the existing shell, dedicated air handling for the classified block, utility routing through existing structure, LN2 and gas supply added outside, and cryo storage in a room designed for it. Ceiling height, structure for the mechanical load and a workable material flow are the constraints to check first.
What is the pressure cascade in a cell and gene therapy facility?
A designed set of pressure differentials that protects product (positive from cleaner to less-clean rooms) and, in vector suites, contains hazards (negative to the corridor), managed through bubble and sink airlocks so both are achieved. It is more complex than in a conventional plant and is commissioned and monitored as one system.
What is chain of identity and how does the facility support it?
The documented link between a patient and their cells through collection, manufacturing and return. The facility supports it with segregated suites or scheduled segregation between batches, labeled and monitored storage, validated transfer routes with temperature logging, and layouts that prevent two batches from being open in the same space at the same time.
How much fixed stainless process equipment does a cell therapy plant have?
Little, compared with a biologics plant: buffer and media preparation vessels, WFI and utility systems, autoclaves and washers. Product-contact processing is mostly single-use, so CIP and SIP scope is small and the contractor’s work is suites, utilities and equipment connections rather than large vessel installation.
Where are cell and gene therapy facilities being built?
Around Boston and Cambridge, Philadelphia, the Research Triangle, the San Francisco Bay Area and Maryland, in purpose-built plants and converted laboratory and industrial buildings. Capacity is also being added by contract manufacturers in the Midwest and Southeast; our state pages describe the conditions in each cluster.
What regulations govern a cell and gene therapy facility?
21 CFR 211 for drug GMP and 21 CFR 1271 for human cells, tissues and cellular and tissue-based products in the United States, with FDA guidance for CGT manufacturing; EU GMP Part IV and Annex 1 in Europe; and ISO 14644 for cleanroom classification. Biosafety requirements apply to vector operations.
How are incubators and freezers served by facility utilities?
Incubators need CO2 and sometimes oxygen and nitrogen at controlled quality, and stable room conditions; controlled-rate freezers need liquid nitrogen; some equipment needs chilled water or glycol. Each supply is designed with redundancy and alarms, because a loss during a run can cost a batch that cannot be remade.
What effluent handling does a vector suite need?
Liquid waste from vector operations is decontaminated by a kill system (heat or chemical) before discharge, with validated cycles and records; solid waste is autoclaved or chemically inactivated. The kill system is a process system in its own right, installed with its tanks, heating, chemical feed and controls, and qualified.
What is the role of isolators in cell therapy manufacturing?
Isolators provide the Grade A environment for open manipulations while separating the operator from the product, allowing the surrounding room to be Grade C or D and reducing gowning and monitoring burden. They need clean utilities, VHP decontamination and integration with the suite’s HVAC and pressure cascade, which is contractor scope.
How long does a cell therapy suite build take?
Modular suites in an existing building typically run from design through certification in months rather than years, with the utility installation and the qualification of HVAC, water and gas systems on the critical path. Equipment lead times and the closed/open classification decision made early are what keep the schedule.
What is Paul Industries’ scope on a cell and gene therapy build?
Classified suites with airlocks and VHP-compatible finishes; clean utilities to validated points of use including WFI, gases, clean steam and vacuum; LN2 and cryogenic piping with oxygen monitoring; glycol and chilled water; buffer and media preparation; autoclave installation; effluent decontamination; and installation and connection of closed processing equipment, isolators and biosafety cabinets, with qualification support.
What decides cell and gene therapy facility design more than anything else?
Whether each unit operation is closed or open. Cell and gene therapy facility design starts by classifying every step: closed single-use operations can sit in Grade C or D suites, open manipulations need a Grade A device in a Grade B suite, and vector work needs containment. That classification sets the number and grade of suites, the airlocks, the gowning and most of the cost, and it is made before the suites are drawn.
Related: Process Systems for Biotech & Biopharmaceutical Manufacturing · Sterile Injectable & Aseptic Fill-Finish Process Systems · Cleanroom Construction & Contractor Services · High-Purity Water System Installation (USP, WFI, RO/DI) · Bioreactor & Fermenter Installation · Sanitary Process Piping Installation (ASME BPE) · Process-Equipment & Sanitary-Piping Contractor in Massachusetts · Iso 7 cleanroom requirements · Request a quote · Cell and Gene Therapy Cleanroom Construction